FDA
FDA Panel Rejects Lykos Therapeutics’ MDMA for PTSD Application
An FDA advisory panel voted against approving Lykos Therapeutics’ MDMA-assisted therapy…
Edited by:
David Connell
Cybin’s Psilocybin Program Granted FDA Breakthrough Designation
FDA support for psychedelics continues as Cybin’s psilocybin program for depression…
Written by:
Jason Najum
Psychedelic News Roundup: LSD Receives FDA Breakthrough Status & Canadian Grey-Market Mushroom Store is Back in Business
Explore the latest in psychedelic news, including the reinstatement of a…
Edited by:
David Connell
MindMed Receives FDA Breakthrough Therapy Designation For LSD
Major news in the psychedelic medicine industry as MindMed has received…
Written by:
Jason Najum